Response by Nassif and Kosiborod to Letter Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes"

Circulation. 2019 Jan 8;139(2):305-306. doi: 10.1161/CIRCULATIONAHA.118.037668.

Authors

Michael E Nassif^{1

2}, Mikhail Kosiborod^{1

2}

Affiliations

¹ Saint Luke's Mid America Heart Institute, Kansas City, MO (M.E.N., M.K.).
² University of Missouri-Kansas City (M.E.N., M.K.).

PMID: 30615504
DOI: 10.1161/CIRCULATIONAHA.118.037668

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiologists
Cardiovascular System*
Glucose
Humans
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Sodium-Glucose Transporter 2 Inhibitors
Glucose